Bloomberg News

Total-Backed Amyris Gets $11 Million for Research on Farnesene

August 14, 2014

Amyris Inc. (AMRS:US), the biotechnology company partially owned by Total SA (FP), received almost $11 million from France’s largest oil producer to continue researching the chemical compound farnesene.

The debt taken on by Emeryville, California-based Amyris came from convertible notes, Joel Velasco, a company spokesman, said today in an e-mail.

Total, Amyris’s largest shareholder, owned almost 21 percent of Amyris as of May 29, according to data (AMRS:US) compiled by Bloomberg.

Amyris deploys genetically modified microorganisms to convert plant sugars into fragrance oils or farnesene, a hydrocarbon used to make specialty chemicals or fuels.

To contact the reporter on this story: Justin Doom in New York at jdoom1@bloomberg.net

To contact the editors responsible for this story: Reed Landberg at landberg@bloomberg.net Robin Saponar


Cash Is for Losers
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • AMRS
    (Amyris Inc)
    • $2.98 USD
    • 0.05
    • 1.68%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus